Designing and implementing a new quality control concept in line with the U.S. Pharmaceutical Authority (FDA) requirements. (Q3751766)

From EU Knowledge Graph
Revision as of 14:41, 24 November 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q3751766 in France
Language Label Description Also known as
English
Designing and implementing a new quality control concept in line with the U.S. Pharmaceutical Authority (FDA) requirements.
Project Q3751766 in France

    Statements

    0 references
    85,310 Euro
    0 references
    197,431.0 Euro
    0 references
    43.21 percent
    0 references
    21 December 2017
    0 references
    31 March 2019
    0 references
    PHARMATORY OY
    0 references
    0 references

    65°2'59.10"N, 25°32'43.91"E
    0 references
    90620
    0 references
    Hankkeen pääasiallisena tavoitteena on liiketoiminnan kansainvälistäminen ja vankan jalansijan saavuttaminen USA:n markkinoilla. Tämä edellyttää toiminnalta FDA-vaatimusten mukaisuutta. Toimenpiteinä suunnitellaan ja toteutetaan analyysi- ja laadunvalvontalaboratorion laajennus ja uudistus koskien sekä laitekantaa että ohjelmistoja ja tietojärjestelmää. Uudistuksen tuloksena yritys pystyy tarjoamaan palveluita USA:n lääkemarkkinoille kyberturvallisuus huomioiden. (Finnish)
    0 references
    The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking into account cybersecurity. (English)
    23 November 2021
    0 references

    Identifiers

    0 references